European equities traded in the US as American depositary receipts were slightly higher late Wednesday morning, rising 0.15% to 1,345.27 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by software firm SAP (SAP) and furniture maker Natuzzi (NTZ), which increased 4.3% and 2.9%, respectively. They were followed by biopharmaceutical company argenx (ARGX) and internet advertising firm Criteo (CRTO), which were up 1.9% and 1.7%, respectively.
The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and accommodations booking company trivago (TRVG), which dropped 5.8% and 4.7%, respectively. They were followed by semiconductor company Sequans Communications (SQNS) and biotech firm Evaxion Biotech (EVAX), which were down 2.7% and 2.4%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company TC Biopharm (TCBP) and pharmaceutical company Silence Therapeutics (SLN), which advanced 10% and 2.2%, respectively. They were followed by software firm Endava (DAVA) and cruise line operator Carnival (CUK), which rose 2% and 1.9%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firm Trinity Biotech (TRIB), which fell 6.5% and 4.6%, respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which lost 3% and 2.9%, respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。